The beta cell-immune cell interface in type 1 diabetes (T1D).

Area of Science:

• Immunology
• Endocrinology
• Cell Biology

Background:

• Type 1 diabetes (T1D) is an autoimmune disease characterized by immune cell infiltration and destruction of pancreatic islet beta cells.
• Current understanding of islet infiltration and immune cell-beta cell interactions in human T1D remains incomplete.
• Translating successful therapies from murine models to human T1D has been challenging.

Purpose of the Study:

• To review the current understanding of the T cell-beta cell interface in human T1D.
• To identify knowledge gaps concerning immune cell infiltration and beta cell function in T1D etiology.
• To highlight the active role of beta cells in autoimmune disease progression.

Main Methods:

• Review of current literature on T1D pathogenesis.
• Analysis of pancreatic and immune cell phenotypes in T1D.
• Focus on the T cell-beta cell interaction axis.

Main Results:

• Pancreatic beta cells play an active role in T1D autoimmune progression.
• The T cell-beta cell interface critically influences beta cell fate and autoimmune responses.
• Beta cell responses to internal/external cues, including HLA class I hyperexpression, contribute to immune cell attraction and tolerance breakdown.

Conclusions:

• Accelerated development of comprehensive human T1D study approaches is ongoing.
• Revised understanding emphasizes the active role of beta cells in T1D pathogenesis.
• Insights into T1D initiation and progression will drive novel therapeutic interventions.